中国地方病学杂志
中國地方病學雜誌
중국지방병학잡지
CHINESE JOURNAL OF ENDEMIOLOGY
2010年
1期
98-100
,共3页
刘辉%董薇%张亚旭%邓睛%宋久成%高本%刘宁%刘运起
劉輝%董薇%張亞旭%鄧睛%宋久成%高本%劉寧%劉運起
류휘%동미%장아욱%산정%송구성%고본%류저%류운기
大骨节病%膝关节%X线%软骨素硫酸盐类%硫酸氨基葡萄糖
大骨節病%膝關節%X線%軟骨素硫痠鹽類%硫痠氨基葡萄糖
대골절병%슬관절%X선%연골소류산염류%류산안기포도당
Kaschin-Beck disease%Knee joint%X-rays%Chondroitin sulfate%Ghcosamine sulfate
目的 观察硫酸软骨素和硫酸氨基葡萄糖对大骨节病的疗效.方法 2007年7月,在黑龙江省尚志市光辉村按<大骨节病诊断标准>检出患者80例.按病情等级、年龄、性别将80例患者分成治疗组、对照组.每组40人.治疗组给予硫酸软骨素和硫酸氨基葡萄糖治疗,对照组给予安慰剂(等量淀粉).在治疗前及治疗后(第8个月)对患者进行直立体位的膝关节X线拍片,利用刻度放大镜测量X线膝关节腔宽度.结果 对照组治疗前、后的X线膝关节腔宽度分别为(4.30±2.14)、(4.10±2.07)mm,治疗组分别为(4.17±2.15)、(4.16±2.11)mm.药物对X线关节腔宽度没有影响(F=0.50,P>0.05),时间、药物与时间的交互作用对X线关节腔宽度有影响(F值分别为67.66、46.74,P均<0.05).治疗组X线关节腔宽度治疗前低于对照组(P<0.05),治疗后高于对照组(P<0.05);对照组治疗前X线关节腔宽度高于治疗后(P<0.05).结论 硫酸软骨素和硫酸氨基葡萄糖减缓了成人大骨节病患者膝关节间隙继续变窄的进程,对关节软骨起到了保护作用,为成人大骨节病治疗在药物选择和疗效判定上提供了依据.
目的 觀察硫痠軟骨素和硫痠氨基葡萄糖對大骨節病的療效.方法 2007年7月,在黑龍江省尚誌市光輝村按<大骨節病診斷標準>檢齣患者80例.按病情等級、年齡、性彆將80例患者分成治療組、對照組.每組40人.治療組給予硫痠軟骨素和硫痠氨基葡萄糖治療,對照組給予安慰劑(等量澱粉).在治療前及治療後(第8箇月)對患者進行直立體位的膝關節X線拍片,利用刻度放大鏡測量X線膝關節腔寬度.結果 對照組治療前、後的X線膝關節腔寬度分彆為(4.30±2.14)、(4.10±2.07)mm,治療組分彆為(4.17±2.15)、(4.16±2.11)mm.藥物對X線關節腔寬度沒有影響(F=0.50,P>0.05),時間、藥物與時間的交互作用對X線關節腔寬度有影響(F值分彆為67.66、46.74,P均<0.05).治療組X線關節腔寬度治療前低于對照組(P<0.05),治療後高于對照組(P<0.05);對照組治療前X線關節腔寬度高于治療後(P<0.05).結論 硫痠軟骨素和硫痠氨基葡萄糖減緩瞭成人大骨節病患者膝關節間隙繼續變窄的進程,對關節軟骨起到瞭保護作用,為成人大骨節病治療在藥物選擇和療效判定上提供瞭依據.
목적 관찰류산연골소화류산안기포도당대대골절병적료효.방법 2007년7월,재흑룡강성상지시광휘촌안<대골절병진단표준>검출환자80례.안병정등급、년령、성별장80례환자분성치료조、대조조.매조40인.치료조급여류산연골소화류산안기포도당치료,대조조급여안위제(등량정분).재치료전급치료후(제8개월)대환자진행직입체위적슬관절X선박편,이용각도방대경측량X선슬관절강관도.결과 대조조치료전、후적X선슬관절강관도분별위(4.30±2.14)、(4.10±2.07)mm,치료조분별위(4.17±2.15)、(4.16±2.11)mm.약물대X선관절강관도몰유영향(F=0.50,P>0.05),시간、약물여시간적교호작용대X선관절강관도유영향(F치분별위67.66、46.74,P균<0.05).치료조X선관절강관도치료전저우대조조(P<0.05),치료후고우대조조(P<0.05);대조조치료전X선관절강관도고우치료후(P<0.05).결론 류산연골소화류산안기포도당감완료성인대골절병환자슬관절간극계속변착적진정,대관절연골기도료보호작용,위성인대골절병치료재약물선택화료효판정상제공료의거.
Objective To research the curative effect of chondroitin sulfate and glucosamine on Kashin-Beck disease(KBD). Methods According to Diagnosis for Kashin-Beck disease,80 patients of adult KBD were detected from Guanghui village Shangzhi city Heilongjiang province in July,2007,and they divided into treatment group and control group according to their condition,age and sex,40 person in each group. Treatment group was given chondroitin sulfate and glucosamine sulfate,and control group was given placebo(equivalent amount of starch). Bilateral knees X-ray films were shot before and after treatment (8th month),scale division magnifying glass was used to measure the width of joint space on X-ray films. Results The width of joint space respectively was (4.30±2.14) and (4.10±2.07)mm in control group before and after treatment,and treatment group respectively was (4.17±2.15),(4.16±2.11)mm. Medicine had no obviously role on joint space (F = 0.50,P > 0.05),Time and both of time and medicine had obvious role on joint space(F= 67.66,46.74,all P< 0.05). Joint space of treat group was thinner than control group(P < 0.05) before treatment,but thicker after treatment(P < 0.05). To compare with the width of before treatment,joint space width of control group became obviously narrow(P < 0.05). Conclusions Experimental group taking chondroitin sulfate and glucosamine sulfate alleviated knee joint space narrowing process of adults KBD patients compared with control group. It plays a protection role in articular cartilage and provides evidences for choosing drug and evaluating effect in the treatment of adults KBD.